Impact Factor
3.88
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.91
1,115 total citations
h5-index
35
h5 depth signal
Cited share
81.7%
196 of 240
Total citations
1,115
Citation footprint
Metric signal
4.44
External metric anchor
Self-citation
1.6%
18 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
728
Canada
95
Australia
82
United Kingdom
66
France
42
Citing Fields of Research
Oncology
407
Breast Cancer
269
Palliative Care
133
Liver & Colon Cancer
105
Prostate Cancer
71
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
988
Articles tracked across the journal lifetime
Indexed publication set
240
196 cited publications
Last 12 months
134
11.2 publications/month
Open access share
91.8%
123 OA publications in the last year
Leading citing country
United States
728 citing publications
Leading citing field
Oncology
407 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v5n1, Feb. 2021-
v1n1, 2017-
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Breast Cancer
Prostate Cancer
Palliative Care
Liver & Colon Cancer
Broad Categories
Neoplasms
Palliative Care
Breast Cancer
Prostate Cancer
Liver & Colon Cancer
Medical Ethics
Lung Cancer
MeSH Descriptors
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1093/jncics/pkag115
Open DOI
When Actionable Genomic Findings Do Not Translate into Treatment in Precision Oncology
Comprehensive genomic profiling has expanded the ability to identify potentially actionable molecular alterations across cancers, but identification of an actionable finding does not ensure that a patient will receive a genomically match...
02
DOI 10.1093/jncics/pkag111
Open DOI
Survival over two decades in neuroendocrine neoplasms care
Background: The incidence of gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs) has increased, alongside novel therapies and care models. Whether these advances translated into improved survival is unclear. Methods: Population-...
03
DOI 10.1093/jncics/pkag110
Open DOI
COVID-19 and thrombotic risk in patients with active cancer: a matched cohort study
COVID-19 has been associated with an increased thrombotic risk, potentially exacerbated in patients with active cancer. We conducted a retrospective cohort study including 119 cancer patients with COVID-19 and 214 matched pre-pandemic co...
04
DOI 10.1093/jncics/pkag108
Open DOI
Plasma metabolomic profiles associated with breastfeeding history and subsequent ovarian cancer risk
Background: Breastfeeding reduces ovarian cancer risk, but the underlying biological mechanisms remain unclear. Methods: We examined the association between a previously reported metabolite-based breastfeeding score with incident epithel...
05
DOI 10.1093/jncics/pkag109
Open DOI
Historical redlining and breast cancer screening in a regional spatial analysis
Background: Redlining, introduced in 1933 by the Homeowners’ Loan Corporation, created enduring structural inequities in housing, health care access, and neighborhood investment. These historical patterns may contribute to persistent dis...
06
DOI 10.1093/jncics/pkag106
Open DOI
Provider communication about colorectal cancer screening tests among U.S. Adults
This cross-sectional study examined patient-provider communication about colorectal cancer screening options using the 2024 Health Information National Trends Survey. The outcome measure was respondents’ report of being informed by a hea...
07
DOI 10.1093/jncics/pkag107
Open DOI
Population‑based registry analysis of cervical cancer trends in Tashkent Uzbekistan 2014–2024
Introduction: Cervical cancer remains a leading cause of morbidity and mortality among women in Uzbekistan, exceeding WHO elimination targets. Despite a school-based HPV vaccination program launched in 2019, screening coverage remains lo...
08
DOI 10.1093/jncics/pkag104
Open DOI
Swedish matched-cohort on the association between maternal polyendocrine metabolic ovarian syndrome and next-generation cancer-risk
Background: Polyendocrine metabolic ovarian syndrome (PMOS) is an endocrine and metabolic disorder associated with adverse perinatal and long-term health outcomes, yet its impact on cancer risk in children remains unclear. Methods: We co...
09
DOI 10.1093/jncics/pkag102
Open DOI
Platform-Agnostic Quantification for Molecular Interception of Oral and Esophageal Malignancies: A Global Study Addressing Diagnostic Divide
Background: Oral and esophageal squamous cell carcinomas (OSCC/ESCC) are commonly diagnosed late since histopathology is subjective and robust molecular tools are lacking. Leveraging interpretable machine learning, we aimed to develop an...
10
DOI 10.1093/jncics/pkag101
Open DOI
Genetic and cellular architecture of breast cancer risk across ancestries
Background: Breast cancer genome-wide association studies (GWAS) have identified more than 200 susceptibility loci, but most studies are dominated by European and East Asian populations. Methods: We analyzed breast cancer GWAS summary st...
Bibliographical & Catalog Notes
Sister journal to: Journal of the National Cancer Institute.
Complemented by (work): Journal of the National Cancer Institute 0027-8874 (DLC) 40029172 (OCoLC)1064763 (DNLM)7503089.